Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 9341

1.

Compounded Low-dose Naltrexone for the Treatment of Guttate Psoriasis: A Case Report.

Muller G, Grieshaber R, Talley JF, Riepl M, Fellows D.

Int J Pharm Compd. 2018 Jul-Aug;22(4):270-278.

PMID:
30021181
2.

Evaluation of Chemical Immobilization in Captive Black Bears ( Ursus americanus) Receiving a Combination of Nalbuphine, Medetomidine, and Azaperone.

Wolfe LL, Wood ME, Fisher MC, Sirochman MA.

J Wildl Dis. 2018 Jul 17. doi: 10.7589/2018-03-079. [Epub ahead of print]

PMID:
30016210
3.

Centrally Acting Agents for Obesity: Past, Present, and Future.

Coulter AA, Rebello CJ, Greenway FL.

Drugs. 2018 Jul 16. doi: 10.1007/s40265-018-0946-y. [Epub ahead of print] Review.

PMID:
30014268
4.

Extended-release naltrexone overlooked in opioid use disorders guideline.

Rieb LM.

CMAJ. 2018 Jul 16;190(28):E862. doi: 10.1503/cmaj.69411. No abstract available.

PMID:
30012803
5.

Persistence of Newer Anti-Obesity Medications in a Real-World Setting.

Ganguly R, Tian Y, Kong SX, Hersloev M, Hobbs T, Gabriel Smolarz B, Ramasamy A, Lundegaard Haase C, Weng W.

Diabetes Res Clin Pract. 2018 Jul 12. pii: S0168-8227(18)30942-2. doi: 10.1016/j.diabres.2018.07.017. [Epub ahead of print]

PMID:
30009937
6.

Proopiomelanocortin (POMC) sequencing and developmental delay: Preliminary evidence for a SNP in the 3' UTR region of the POMC gene-Possible relevance for biological risk and self-injurious behavior.

Damerow JA, Tervo RC, Ehrhardt M, Panoskaltsis-Mortari A, Symons FJ.

Dev Psychopathol. 2018 Jul 16:1-6. doi: 10.1017/S0954579418000718. [Epub ahead of print]

PMID:
30009717
7.

Naltrexone.

Drugs and Lactation Database (LactMed) [Internet]. Bethesda (MD): National Library of Medicine (US); 2006-.

8.

Combination Therapies for Obesity.

Camilleri M, Acosta A.

Metab Syndr Relat Disord. 2018 Jul 11. doi: 10.1089/met.2018.0075. [Epub ahead of print]

PMID:
29993319
9.

Moving Addiction Care to the Mainstream - Improving the Quality of Buprenorphine Treatment.

Saloner B, Stoller KB, Alexander GC.

N Engl J Med. 2018 Jul 5;379(1):4-6. doi: 10.1056/NEJMp1804059. No abstract available.

10.

Mu Opioid Receptor Agonist DAMGO Produces Place Conditioning, Abstinence-induced Withdrawal, and Naltrexone-Dependent Locomotor Activation in Planarians.

Dziedowiec E, Nayak SU, Gruver KS, Jennings T, Tallarida CS, Rawls SM.

Neuroscience. 2018 Jun 27;386:214-222. doi: 10.1016/j.neuroscience.2018.06.029. [Epub ahead of print]

PMID:
29958944
11.

Comment on "Review of Case Narratives from Fatal Overdoses Associated with Injectable Naltrexone for Opioid Dependence".

Silverman B, Bloomgren G, Jain P, Marcopul K, Silveira A, Fratantonio J, Sullivan M, Akerman S.

Drug Saf. 2018 Jun 28. doi: 10.1007/s40264-018-0691-x. [Epub ahead of print] No abstract available.

PMID:
29956220
12.

Authors' Response to Silverman and Colleagues' Comment on "Review of Case Narratives from Fatal Overdoses Associated with Injectable Naltrexone for Opioid Dependence".

Dasgupta N, Saucier R, Wolfe D.

Drug Saf. 2018 Jun 28. doi: 10.1007/s40264-018-0692-9. [Epub ahead of print] No abstract available.

PMID:
29956219
13.

Efficacy of long-acting, injectable versus oral naltrexone for preventing admissions for alcohol use disorder.

Beatty A, Stock C.

Ment Health Clin. 2018 Mar 23;7(3):106-110. doi: 10.9740/mhc.2017.05.106. eCollection 2017 May.

14.

Effects of extended-release naltrexone on the brain response to drug-related stimuli in patients with opioid use disorder.

Shi Z, Wang AL, Jagannathan K, Fairchild VP, O'Brien CP, Childress AR, Langleben DD.

J Psychiatry Neurosci. 2018 Jul;43(4):254-261.

15.
16.

Effects of medication-assisted treatment on mortality among opioids users: a systematic review and meta-analysis.

Ma J, Bao YP, Wang RJ, Su MF, Liu MX, Li JQ, Degenhardt L, Farrell M, Blow FC, Ilgen M, Shi J, Lu L.

Mol Psychiatry. 2018 Jun 22. doi: 10.1038/s41380-018-0094-5. [Epub ahead of print]

PMID:
29934549
17.

Office-Based Addiction Treatment in Primary Care: Approaches That Work.

Edelman EJ, Oldfield BJ, Tetrault JM.

Med Clin North Am. 2018 Jul;102(4):635-652. doi: 10.1016/j.mcna.2018.02.007. Review.

PMID:
29933820
18.

Evaluation of morphine-like effects of the mixed mu/delta agonist morphine-6-O-sulfate in rats: Drug discrimination and physical dependence.

Yadlapalli JSK, Bommagani SB, Mahelona RD, Wan A, Gannon BM, Penthala NR, Dobretsov M, Crooks PA, Fantegrossi WE.

Pharmacol Res Perspect. 2018 Jun 19;6(4):e00403. doi: 10.1002/prp2.403. eCollection 2018 Jul.

19.

Management of Chronic Hepatic Itch.

Düll MM, Kremer AE.

Dermatol Clin. 2018 Jul;36(3):293-300. doi: 10.1016/j.det.2018.02.008. Epub 2018 May 1. Review.

PMID:
29929600
20.

Medication for Opioid Use Disorder After Nonfatal Opioid Overdose and Association With Mortality: A Cohort Study.

Larochelle MR, Bernson D, Land T, Stopka TJ, Wang N, Xuan Z, Bagley SM, Liebschutz JM, Walley AY.

Ann Intern Med. 2018 Jun 19. doi: 10.7326/M17-3107. [Epub ahead of print]

PMID:
29913516

Supplemental Content

Loading ...
Support Center